Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance

BACKGROUND: In normal circumstances, AT secretes anti-inflammatory adipokines (AAKs) which regulates lipid metabolism, insulin sensitivity, vascular hemostasis, and angiogenesis. However, during obesity AT dysfunction occurs and leads to microvascular imbalance and secretes several pro-inflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Probin Kr, Islam, Johirul, Lalhlenmawia, Hauzel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073393/
https://www.ncbi.nlm.nih.gov/pubmed/37014444
http://dx.doi.org/10.1186/s43044-023-00352-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073393/
https://www.ncbi.nlm.nih.gov/pubmed/37014444
http://dx.doi.org/10.1186/s43044-023-00352-7

Ejemplares similares